381 results on '"Pierini, Antonio"'
Search Results
2. How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia
3. A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect
4. Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice.
5. Donor natural killer cells trigger production of β-2-microglobulin to enhance post–bone marrow transplant immunity
6. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway
7. The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).
8. First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies
9. Total Marrow/Lymphoid Irradiation in the Conditioning Regimen for Haploidentical T-Cell-Depleted Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: The Perugia Experience
10. Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
11. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models
12. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
13. Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group.
14. Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation
15. Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation
16. TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation
17. No tolerance with immune suppression!
18. PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION
19. P813: MALIGNANT PLASMA CELLS PROMOTE EXPANSION OF REGULATORY T CELLS TO CREATE A PROTECTIVE “IMMUNE SHIELD”
20. T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease
21. Clinical-Grade–Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell–Dependent Graft-versus-Leukemia Effect in Murine Models
22. Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
23. Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis
24. Blinatumomab Redirects Donor Lymphocytes against CD19 + Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
25. The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia
26. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease
27. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease
28. Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality
29. Haploidentical hematopoietic transplantation from KIR ligand–mismatched donors with activating KIRs reduces nonrelapse mortality
30. Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
31. HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients
32. Novel Tissue-Specific Targeted Radiation Delivery Reduces GI Injury and T Cell Trafficking Attenuating Allogeneic Immune Attack to Reduce GvHD in a Murine BMT Model
33. Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice
34. CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells
35. Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality
36. Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement
37. “Designed” grafts for HLA-haploidentical stem cell transplantation
38. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells
39. Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation
40. Regulatory T Cell Immunotherapy in Immune-Mediated Diseases
41. T regulatory cell separation for clinical application
42. FISH analysis reveals frequent co-occurrence of 4q24/ TET2 and 5q and/or 7q deletions
43. New mechanism of lymphoma-induced bone marrow aplasia
44. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
45. Acute GvHD after HLA-Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes
46. Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice.
47. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity
48. Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
49. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35
50. HLA-Haploidentical Transplantation with Regulatory and Conventional T-Cells Adoptive Immunotherapy in Pediatric Patients with High-Risk Acute Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.